Is an Executive Physical Worth It? What the Evidence Actually Says

Two patients taught me the same lesson from opposite directions.

The first was a man in his fifties who had done everything a careful person is supposed to do. For years he had shown up for his annual physical, sat through the fifteen minutes, had his blood pressure and a basic cholesterol panel checked, and been told he was fine. See you next year. He believed it, because why wouldn't he. It was only when he finally had a proper evaluation that we found the cardiovascular risk a decade of quick visits had never gone looking for. The disease had been there the whole time. No one had asked the right question.

The second had the opposite problem. Healthy, no complaints, she had paid out of pocket for a one-morning executive physical at a program that ran nearly every test it owned. One of the scans lit up something incidental, a small finding with the kind of report language that ends your weekend: cannot exclude malignancy, recommend further evaluation. What followed was months of it. A repeat scan, then a specialist, then another scan, real cost, and a season of fear. In the end it was nothing, as most of these are. But she did not get those months back.

Different people, opposite mistakes, and the same question underneath: what should a serious health evaluation actually be? Here is the answer I have arrived at after watching both failures up close. The best executive physical is not the one that runs the most tests. It is the one run by someone whose job is to protect you from both a missed diagnosis and an unnecessary one.

The part the brochure leaves out

Start with the uncomfortable evidence, because an honest article has to. The routine comprehensive checkup, the yearly ritual for people with no symptoms, has a surprisingly thin record. The most rigorous summary we have is a Cochrane review that pooled eleven randomized trials and more than 233,000 people. General health checks did not lower the death rate. Not overall, where the relative risk landed at exactly 1.00, and not for heart disease or cancer specifically. The authors' conclusion was blunt: general health checks are "unlikely to be beneficial," and may lead to unnecessary tests and treatments.

That is not a fringe position. Writing in the New England Journal of Medicine under the title "Against the Annual Physical," two physicians argued that annual physicals do not reduce illness or death and cost time and money. The Society of General Internal Medicine put it on its Choosing Wisely list of things to question: "Don't perform routine general health checks for asymptomatic adults."

And the executive physical, the premium version sold to busy leaders, has drawn its own critique. In a NEJM piece titled "Executive physicals: bad medicine on three counts," a physician argued the practice "fails on three important counts: efficacy, cost and equity."

So if you are asking whether an executive physical is worth it, you deserve the strongest version of the skeptical case first. As commonly practiced, a menu of every available test run on a healthy person in a single morning, it is not supported by outcome data, and it can leave you worse off than if you had stayed home.

It is worth asking why the default runs toward more when the evidence runs the other way. Part of the answer is human: a long, thorough-looking workup feels like caring, and telling someone you checked everything is easier than telling them you chose not to. Part of it is structural. More tests generate more billing, more findings generate more follow-up, and comprehensive markets better than selective. And fear is the most reliable motivator in medicine. None of that makes the people running these programs cynical. It only means the incentives point toward doing more, and someone has to be paid to point the other way when more is not better.

Why more can be worse

The reason more testing can backfire is not bad luck. It is arithmetic. Look hard enough at a healthy body and you will find something, because there is far more normal tissue to misread than hidden disease to catch. This is the base rate at work: when you go looking for something the person in front of you is unlikely to have, most of what lights up is a false alarm, no matter how good the test. A chest CT turns up an incidental abnormality in close to half the people who get one, and a cardiac MRI in about a third, according to an umbrella review of the evidence in the BMJ. The overwhelming majority are harmless. Even the blood tests designed to catch cancer early run into the same wall: in one study, among the people whose multi-cancer test flagged a possible cancer, most did not turn out to have one. A report that says cannot exclude does not resolve on its own. It becomes an assignment: another scan, a specialist visit, sometimes a biopsy, and the particular dread of waiting to learn whether the thing inside you matters.

A real share of what screening turns up was never going to hurt you. In a well-known analysis, researchers estimated that many screen-detected cancers are overdiagnosed, meaning they would never have caused symptoms in a lifetime: on the order of a quarter of screen-detected breast cancers and more than half of PSA-detected prostate cancers. Finding those earlier does not help. Treating them can hurt.

This is the pattern I keep returning to in these pages. I have written about how a heart scan can chase a number that turns out to be a poor stand-in for what you actually care about, how a biomarker can move in the right direction while the outcome does not follow, and how a whole-body MRI finds something in almost everyone it scans while missing much of what matters. Each is a version of the same trap that caught my second patient. The test was the easy part. No one had a plan for what to do with what it found.

The other way to be wrong

If I stopped there, the lesson would be "skip the tests," and that would be just as wrong in the other direction. The fifteen-minute physical does not only waste money on the worried well. It also misses real, treatable disease in people who feel fine.

Think of the fit forty-five-year-old whose coronary calcium score is zero but who is quietly accumulating soft, uncalcified plaque the basic workup will never see. Or the person whose standard cholesterol panel looks reassuring while the numbers that better predict risk, things like ApoB or Lp(a), were never measured. Or the patient whose family history should have changed the plan years earlier, if anyone had taken a proper history and mapped it. My first patient lived in that gap for a decade.

So both patients were failed, and neither failure was really about the number of tests. Under-testing missed disease. Over-testing manufactured a crisis out of noise. The dial you want to turn is not "how much." It is "which, and why, and then what." That is a judgment, and judgment is the thing a menu cannot supply.

What a good evaluation actually does

If the number of tests is the wrong thing to optimize, what is the right one? A rigorous evaluation is defined by four things, and none of them is volume.

The first is fit. The tests are chosen for your risks, not copied off a standard sheet. Some people genuinely benefit from a coronary calcium score. For others it is a waste, or worse, a doorway to findings that lead nowhere. The value is in knowing which person you are, which starts with actually knowing you.

The second is honesty about evidence. Some tests have earned their place, most with real outcome data behind them: blood-pressure and lipid management, colon cancer screening, low-dose CT for a heavy smoking history, a calcium score for the middle-aged adult whose risk is genuinely uncertain. Others are informative but unproven, and a good evaluation says so out loud. Multi-cancer early-detection blood tests and whole-body MRI belong in that second tier. They are promising, and occasionally the right tool for a specific person. But neither has been shown to help anyone live longer, and the randomized trials that could prove it have either not reported yet or, in the case of whole-body MRI, not even begun. Offered as one carefully chosen input, that can be reasonable. Sold as reassurance, it is a story.

The third is a plan made before the test, not after. Who reads the result, what threshold triggers action versus watchful waiting, and what we will and will not do about an ambiguous finding, all decided in advance. No patient should be alone with a frightening report at eleven at night because no one thought past ordering the scan.

The fourth is time. Interpreting all of this, in the context of a whole person rather than a reference range, is the actual product. It does not fit in fifteen minutes, which is precisely why the standard physical keeps missing what it misses.

None of this is an argument for testing less as a virtue. It is an argument for spending the effort where the evidence is. For most people that points to the same unglamorous, high-yield targets: the cardiometabolic risk that drives most premature death, characterized properly instead of with a single cholesterol number; the cancer screens that genuinely have outcome data behind them, done on schedule; how well you move and use oxygen; your metabolic health, your sleep, how much you drink, your mental health. None of these photograph well in a brochure. They are simply where the leverage is.

Two ways to use one evaluation

Here is something the sales pitch usually skips: a good evaluation is worth having even if you never come back.

It can stand alone. You get a rigorous baseline and a written strategy in plain language, to take to whatever physician you already trust. Nothing about its value depends on signing up for anything else. Or it can be a foundation. If you want help carrying out the plan, it can become the starting point for ongoing care, either with us or handed back to your regular doctor with a clear, prioritized roadmap and a solid start. The evaluation earns its keep on its own terms. It is not a turnstile into a membership, and it should never be sold as one.

Common questions

Is an executive physical worth it?

For the right person, done the right way, it can be genuinely valuable. For the average healthy adult seeking reassurance, a do-everything physical is unproven and can create problems it then has to chase. The worth is not in the length of the test menu. It is in whether a physician tailors the evaluation to your risks, reads the findings in context, and has a plan for them.

Isn't the annual physical proven to keep me healthy?

Not the comprehensive checkup itself. Large randomized trials, pooled in a Cochrane review of more than 233,000 people, found that routine general health checks did not lower the rate of death from any cause, including heart disease and cancer. What does help is specific, evidence-based screening matched to your age and risk, such as blood-pressure control, colon cancer screening, and treating high cholesterol. The ritual of the yearly exam is not what protects you. The right targeted actions are.

What is the difference between a standard physical and an executive physical?

Mostly depth, time, and interpretation, not simply more tests. A standard physical is a brief visit with basic labs. A well-designed executive evaluation spends real time understanding you, selects advanced tests only where your risks warrant them, and delivers a written strategy you can act on. Done poorly, an executive physical is just a longer menu of tests run on a healthy person, which is where the over-testing harms come from.

Do I have to join a concierge practice to get one?

No. A good evaluation stands on its own. You can take it as a one-time assessment, with a written report and recommendations you bring to your own physician, or you can use it as the foundation for ongoing care if you want help carrying out the plan. The value does not depend on becoming a member.

Can more testing actually be harmful?

Yes, and this is the part most people underestimate. Screening a healthy body tends to find incidental abnormalities, close to half of people on some scans, and the great majority are harmless. But an ambiguous finding can set off a cascade of follow-up scans, specialist visits, and occasionally biopsies, with real cost, anxiety, and sometimes physical harm, for something that was never going to threaten your health. A good evaluation is designed to minimize that, not to maximize what it finds.

How we approach this at My Doctor Medical Group

So how do we handle this for the people in our practice? We try to do more than the standard physical, because it misses too much, and less than the do-everything menu, because that harms. Every test on your evaluation is there for a reason specific to you. Before we order anything, we decide who will read it and what we will do with the answer. The goal is the one I keep coming back to: to protect you from both a missed diagnosis and an unnecessary one.

In the interest of straight dealing, my practice has no financial relationship with any testing company. No equity, no referral fees, no promotional arrangement. When we order an advanced test, it is because it is the right tool for you, not because it is on a menu we profit from.

None of this fits in a rushed visit. Deciding what a thorough evaluation should include for you, and then reading the results without over- or under-reacting, is exactly what our Executive Health evaluation is built around. If you want to think it through with someone whose job is to interpret the tests rather than sell them, you can always contact us.

This content is for educational purposes only and does not constitute medical advice. Consult your physician before making changes to your health regimen.

Sources

• Krogsbøll LT, Jørgensen KJ, Gøtzsche PC. General health checks in adults for reducing morbidity and mortality from disease. Cochrane Database of Systematic Reviews, 2019;1(1):CD009009. DOI: 10.1002/14651858.CD009009.pub3. PMID: 30699470.
• Mehrotra A, Prochazka A. Improving value in health care: against the annual physical. New England Journal of Medicine, 2015;373(16):1485-1487. DOI: 10.1056/NEJMp1507485. PMID: 26465981.
• Rank B. Executive physicals: bad medicine on three counts. New England Journal of Medicine, 2008;359(14):1424-1425. DOI: 10.1056/NEJMp0806270. PMID: 18832242.
• Society of General Internal Medicine. Don't perform routine general health checks for asymptomatic adults. Choosing Wisely, an initiative of the ABIM Foundation, 2013.
• O'Sullivan JW, Muntinga T, Grigg S, Ioannidis JPA. Prevalence and outcomes of incidental imaging findings: umbrella review. BMJ, 2018;361:k2387. DOI: 10.1136/bmj.k2387. PMID: 29914908.
• Welch HG, Black WC. Overdiagnosis in cancer. Journal of the National Cancer Institute, 2010;102(9):605-613. DOI: 10.1093/jnci/djq099. PMID: 20413742.
• Schrag D, Beer TM, McDonnell CH 3rd, et al. Blood-based tests for multicancer early detection (PATHFINDER): a prospective cohort study. The Lancet, 2023;402(10409):1251-1260. DOI: 10.1016/S0140-6736(23)01700-2. PMID: 37805216.
• Bloomfield HE, Wilt TJ. Evidence brief: role of the annual comprehensive physical examination in the asymptomatic adult. VA Evidence-based Synthesis Program, 2011. PMID: 22206110.